Who We Are

VEG: collaboration for personalised epigenetic cancer therapy through pre-clinical evaluation, novel biomarker development and early phase clinical trials of new drugs.

Our Research

Employing clinical trials of ‘epigenetic drugs’ for patients with blood cancers incorporating detailed laboratory studies on how these new drugs work and how to use them better.


In every cell there are chemical reactions that switch genes on and off; this gene control mechanism is called epigenetics and cancer can develop due to abnormal epigenetic reactions. There are exciting drugs in development that can target epigenetic changes to ‘re-programme’ the rogue cancer cell.


Membership is open to individuals who possess the qualifications and experience necessary to be a site or study investigator & support the aims of VEG. The scientific community benefits from the commitment and expertise of its members in delivering epigenetic translational research.

Donation Program

Donation Program

Support our work by making a donation. Contact VEG to find out how.

Publications & Newsletter

General Newsletter: Read more

Subscribe to our Newsletter

Contact us

Contact us:

Have a question or comment? Please contact us using the details below. VEG is located on:

Peter MacCallum Cancer Centre, East Melbourne VIC 3002
03 9656 3588